Metagenomi Therapeutics
MGX · NASDAQ
$0.8313+$0.0195 (+2.40%)TodayMarket closed ·
Prev close $0.8118
About MGX
- Employees
- 119
- Headquarters
- Emeryville, California
- Listed
- Feb 9, 2024
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- metagenomi.co
Leadership
| Name | Title | Since |
|---|---|---|
| Willard Dere | — | — |
| Jian Irish | — | 2021 |
| Brian Thomas | — | 2025 |
| Pamela Wapnick | — | — |
| Matthew Wein | — | — |
| Sarah Noonberg | — | — |
| Laurence Reid | — | — |
| Eric Bjerkholt | — | — |
| Juergen Eckhardt | — | 2024 |
Similar companies
Companies in the same industry as Metagenomi Therapeutics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.